Primary Balloon Angioplasty Versus Hydrostatic Dilation for Arteriovenous Fistula Creation in Patients with Small-Caliber Cephalic Veins: A Systematic Review and Meta-Analysis.
Journal
Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
17
05
2022
revised:
18
07
2022
accepted:
20
07
2022
pubmed:
28
8
2022
medline:
27
12
2022
entrez:
27
8
2022
Statut:
ppublish
Résumé
For arteriovenous fistula (AVF) presence of a venous segment with adequate diameter is essential which is lacking in many patients. To find the optimal augmentation technique in patients with small-caliber cephalic vein (i.e., cephalic vein diameter <3 mm), studies compared primary balloon angioplasty (PBA) versus hydrostatic dilation (HD); however, it remained debatable. This systematic review seeks to determine which technique is preferable. We searched MEDLINE, PubMed, Embase, and Google Scholar. Primary outcomes were 6-month primary patency, reintervention, and working AVF. Secondary outcomes were immediate success, the AVF's maturation time (day), and surgical site infection. Three randomized controlled trials yielding 180 patients were included, of which 89 patients were in the PBA group. The odds ratio (OR) of primary patency was significantly higher in the PBA group (OR 6.09, 95% confidence interval [CI], 2.36-15.76, P = 0.0002), the OR of reintervention was significantly lower in the PBA group (OR 0.16, 95% CI, 0.06-0.42, P = 0.0002), and the OR of working AVF was greater in PBA group (OR 4.22, 95% CI, 1.31-13.59, P = 0.02). The OR of immediate success was significantly greater in the PBA group (OR 11.42, 95% CI, 2.54-51.42, P = 0.002), and the AVF maturation time was significantly shorter in patients who underwent PBA (mean difference -20.32 days, 95% CI, -30.12 to -10.52, P = 0.0001). The certainty of the evidence was high. PBA of small cephalic veins with diameter ≤2.5 cm is a safe, feasible, and efficacious augmentation method for AVF creation. This technique achieves favorable maturation outcomes, and PBA is superior to the standard hydrostatic dilatation technique.
Sections du résumé
BACKGROUND
BACKGROUND
For arteriovenous fistula (AVF) presence of a venous segment with adequate diameter is essential which is lacking in many patients. To find the optimal augmentation technique in patients with small-caliber cephalic vein (i.e., cephalic vein diameter <3 mm), studies compared primary balloon angioplasty (PBA) versus hydrostatic dilation (HD); however, it remained debatable. This systematic review seeks to determine which technique is preferable.
METHODS
METHODS
We searched MEDLINE, PubMed, Embase, and Google Scholar. Primary outcomes were 6-month primary patency, reintervention, and working AVF. Secondary outcomes were immediate success, the AVF's maturation time (day), and surgical site infection.
RESULTS
RESULTS
Three randomized controlled trials yielding 180 patients were included, of which 89 patients were in the PBA group. The odds ratio (OR) of primary patency was significantly higher in the PBA group (OR 6.09, 95% confidence interval [CI], 2.36-15.76, P = 0.0002), the OR of reintervention was significantly lower in the PBA group (OR 0.16, 95% CI, 0.06-0.42, P = 0.0002), and the OR of working AVF was greater in PBA group (OR 4.22, 95% CI, 1.31-13.59, P = 0.02). The OR of immediate success was significantly greater in the PBA group (OR 11.42, 95% CI, 2.54-51.42, P = 0.002), and the AVF maturation time was significantly shorter in patients who underwent PBA (mean difference -20.32 days, 95% CI, -30.12 to -10.52, P = 0.0001). The certainty of the evidence was high.
CONCLUSIONS
CONCLUSIONS
PBA of small cephalic veins with diameter ≤2.5 cm is a safe, feasible, and efficacious augmentation method for AVF creation. This technique achieves favorable maturation outcomes, and PBA is superior to the standard hydrostatic dilatation technique.
Identifiants
pubmed: 36029949
pii: S0890-5096(22)00494-0
doi: 10.1016/j.avsg.2022.07.025
pmc: PMC9833288
mid: NIHMS1860826
pii:
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
351-361Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK124515
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Références
J Vasc Surg. 2001 Dec;34(6):1004-9
pubmed: 11743552
J Vasc Surg. 2001 Nov;34(5):866-71
pubmed: 11700488
J Vasc Surg. 2009 Jun;49(6):1499-504
pubmed: 19497513
Nephrol Dial Transplant. 2003 Jul;18 Suppl 5:v50-2
pubmed: 12817071
Am J Kidney Dis. 2014 Mar;63(3):464-78
pubmed: 24183112
J Vasc Surg. 2010 Jul;52(1):139-44
pubmed: 20471767
J Vasc Surg. 2015 Jan;61(1):170-6
pubmed: 25065580
J Vasc Surg. 2008 Nov;48(5 Suppl):34S-47S
pubmed: 19000592
J Vasc Surg. 2002 Sep;36(3):452-9
pubmed: 12218966
Semin Vasc Surg. 2016 Dec;29(4):153-171
pubmed: 28779782
J Vasc Surg. 1998 Feb;27(2):302-7; discussion 307-8
pubmed: 9510284
Clin J Am Soc Nephrol. 2007 Jul;2(4):786-800
pubmed: 17699495
Anesth Analg. 2009 Sep;109(3):976-80
pubmed: 19690276
Asian Cardiovasc Thorac Ann. 2022 Jun;30(5):524-531
pubmed: 34494903
Am J Kidney Dis. 2003 Nov;42(5):1000-12
pubmed: 14582044
J Vasc Access. 2015 Nov-Dec;16(6):506-11
pubmed: 26109534
Kidney Int. 2002 Oct;62(4):1109-24
pubmed: 12234281
JAMA. 2008 May 14;299(18):2164-71
pubmed: 18477783
Semin Nephrol. 2012 Nov;32(6):558-63
pubmed: 23217336
J Vasc Surg. 2013 Jan;57(1):131-6
pubmed: 23153423
Ultrasound Med Biol. 2006 Jun;32(6):817-22
pubmed: 16785004
Am J Kidney Dis. 2020 Apr;75(4 Suppl 2):S1-S164
pubmed: 32778223
J Vasc Surg. 2013 Jan;57(1):9-18
pubmed: 22960020
Clin J Am Soc Nephrol. 2008 May;3(3):714-9
pubmed: 18256379
Semin Dial. 2012 May;25(3):303-10
pubmed: 22487024
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Am Surg. 2010 Sep;76(9):938-42
pubmed: 20836338
J Vasc Surg. 2016 Jul;64(1):236-43
pubmed: 27345510
J Vasc Surg. 2007 Dec;46(6):1180-90; discussion 1190
pubmed: 18154993
J Vasc Interv Radiol. 2006 May;17(5):807-13
pubmed: 16687746
J Clin Epidemiol. 2021 Jun;134:178-189
pubmed: 33789819
Am J Kidney Dis. 2021 Apr;77(4 Suppl 1):A7-A8
pubmed: 33752804
BMC Med Res Methodol. 2015 Apr 14;15:35
pubmed: 25880989
J Surg Res. 2014 May 1;188(1):162-73
pubmed: 24582063
J Vasc Surg. 2011 Sep;54(3):749-53
pubmed: 21367563
J Vasc Access. 2011 Oct-Dec;12(4):331-5
pubmed: 21928240
J Am Soc Nephrol. 2017 Oct;28(10):3005-3013
pubmed: 28710091
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583